<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Phenoloxidase Activity Acts Mosquito Innate <br /> Immune Response Infection Semliki Forest <br /> Virus <br /> Julio Rodriguez-Andres1,2, Seema Rani1, Margus Varjak3, Margo E. Chase-Topping4, Markus H. Beck5, <br /> Mhairi C. Ferguson1, Esther Schnettler1,2, Rennos Fragkoudis1, Gerald Barry1, Andres Merits3, <br /> John K. Fazakerley1, Michael R. Strand5*, Alain Kohl1,2* <br /> 1 The Roslin Institute Royal (Dick) School Veterinary Studies, University Edinburgh, Easter Bush, Midlothian, United Kingdom, 2 MRC-University Glasgow Centre <br /> for Virus Research, Glasgow, United Kingdom, 3 Institute Technology, University Tartu, Tartu, Estonia, 4 Centre Immunity, Infection Evolution, Ashworth <br /> Laboratories, University Edinburgh, Edinburgh, United Kingdom, 5 Department Entomology, University Georgia, Athens, Georgia, United States America <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Several components mosquito immune including <span id='am-163' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-164' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-184' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-189' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-191' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-212' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-239' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-240' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi), JAK/STAT, Toll IMD <br />      pathways previously implicated controlling arbovirus infections. In contrast, role phenoloxidase (PO) <br />      cascade mosquito antiviral immunity unknown. Here conditioned medium Aedes albopictus- <br />      derived U4.4 cell line contains functional PO cascade, activated bacterium Escherichia coli the <br />      arbovirus Semliki Forest virus (SFV) (Togaviridae; Alphavirus). Production recombinant SFV expressing PO cascade <br />      inhibitor Egf1.0 blocked PO activity U4.4 cell- conditioned medium, resulted enhanced spread SFV. Infection <br />      adult female Aedes aegypti feeding mosquitoes bloodmeal containing Egf1.0-expressing SFV increased virus <br />      replication mosquito mortality. Collectively, results suggest PO cascade mosquitoes plays important role <br />      immune defence arboviruses. <br />  <br />   Citation: Rodriguez-Andres J, Rani S, Varjak M, Chase-Topping ME, Beck MH, et al. (2012) Phenoloxidase Activity Acts Mosquito Innate Immune Response <br />   Infection Semliki Forest Virus. PLoS Pathog 8(11): e1002977. doi:10.1371/journal.ppat.1002977 <br />   Editor: Kenneth D. Vernick, University Minnesota, United States America <br />   Received May 15, 2012; Accepted September 5, 2012; Published November 8, 2012 <br />   Copyright: &#195;&#376; 2012 Rodriguez-Andres et al. This open-access article distributed terms Creative Commons Attribution License, which <br />   permits unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: This work supported Wellcome Trust (079699/Z/06/Z) (AK), BBSRC Roslin Institute Strategic Programme Grant (JKF, AK), UK Medical <br />   Research Council (AK), Netherlands Organisation Scientific Research NWO (Rubicon fellowship, 825.10.021) (ES), National Institutes Health (AI1387643) (MRS) <br />   European Union (European Regional Development Fund, Center Excellence Chemical Biology) (AM). JRA sponsored UK Medical Research <br />   Council studentship. The funders role study design, data collection analysis, decision publish, preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * E-mail: mrstrand@uga.edu (MRS); alain.kohl@glasgow.ac.uk (AK) <br />  <br />  <br />  <br />  <br /> Introduction                                                                            transcribed control subgenomic promoter) is <br />                                                                                         proteolytically cleaved structural proteins form the <br />    The transmission arboviruses mosquitoes                              capsid envelope virion. The glycosylated envelope <br /> arthropod vectors considerable adverse impacts human                         proteins play key roles entry cells mediating virus <br /> animal health. This group pathogens consists primarily                            binding host cell receptor(s) subsequent fusion <span id='am-6' about='protege:TO' typeof='owl:Thing'>to</span> <br /> viruses families Flaviviridae, Togaviridae Bunyaviridae,                     endosomes (though entry mechanisms possible) <br /> Reoviridae [1&#226;&#8364;&#8220;4]. Arboviruses replicate vertebrate                          capsid protein encapsulates viral genome [10&#226;&#8364;&#8220;12]. <br /> arthropod hosts. In mosquitoes, arboviruses spread                       Infection mosquito cell cultures useful study <br /> the midgut, initial site infection following                          arbovirus replication, allowing increasingly detailed studies of <br /> bloodmeal salivary glands transmission                            arbovirus/vector interactions [13,14]. <br /> vertebrate host. The genus Alphavirus (family Togaviridae) contains                        The innate immune mosquitoes plays important <br /> several mosquito-vectored arboviruses including models like                             role control arbovirus infections, SFV proven to <br /> Sindbis virus (SINV) Semliki Forest virus (SFV) [5,6]                           good models study mosquito antiviral response mecha- <br /> also re-emerging human pathogen chikungunya virus                                   nisms [14]. A key antiviral defence RNAi (reviewed [14&#226;&#8364;&#8220;17]), <br /> (CHIKV) [7]. The genetic structure replication alpha-                            influences arbovirus spread transmission [18,19]. <br /> viruses, replicate cytoplasm, analysed                        In addition, differential regulation mosquito immune signalling <br /> detail [5,6,8,9]. All members genus positive-stranded                       pathways host genes described following <br /> RNA genomes approximately 11&#226;&#8364;&#8220;12 kb size,                           infection dengue virus (DENV), West Nile virus (WNV) and <br /> 59 caps 39 poly(A) tails (genetic structure SFV shown                         SINV [20&#226;&#8364;&#8220;24]. JAK/STAT Toll signalling pathways both <br /> Fig. 1A). All alphaviruses encode major polyproteins. The                      mediate antiviral activity DENV [23,24]. Interestingly, <br /> 59 encoded non-structural polyprotein P1234 proteolytically                          infection Anopheles gambiae alphavirus o&#226;&#8364;&#8482;nyong-nyong <br /> cleaved replicase proteins nsP1&#226;&#8364;&#8220;4 39 encoded                             (ONNV) did result upregulation Toll JAK/ <br /> structural polyprotein (translated subgenomic mRNA,                              STAT pathways genes involved immunity were <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                              1                       November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                          PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br />   Author Summary                                                               Another conserved component insect immune is <br />                                                                             extracellular phenoloxidase (PO) cascade, generates <br />   Arboviruses transmitted vertebrates arthropod                   cytotoxic intermediates formation melanin following <br />   vectors mosquitoes. Infection mosquitoes                  wounding infection [28&#226;&#8364;&#8220;32]. Several factors shown <br />   arboviruses activates immune defence responses including                  activate PO cascade including pathogen-associated molec- <br />   <span id='am-85' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-86' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-115' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-124' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-142' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-156' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-161' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span>RNA interference pathway</span>. Another component                    ular <span id='am-241' about='xsp:pattern' typeof='owl:Thing'>pattern</span> molecules like bacterial peptidoglycan. Other <br />   insect immune phenoloxidase (PO) cascade,                   components cascade include multiple clip-domain serine <br />   produces melanin accumulates wound sites                    proteases (cSPs) activation results processing the <br />   invading microorganisms. Some pathogen-                        zymogen prophenoloxidase (PPO proPO) form active PO. <br />   associated pattern recognition molecules known to <br />                                                                             PO catalyses conversion mono- di-phenolic <br />   activate PO cascade, results proteolytic <br />   processing inactive prophenoloxidase (PPO) PO. PO                   substrates quinones, converted melanin. <br />   catalyses formation compounds ultimately                    A number studies shown deposition melanin <br />   form melanin. Some products known                    provides defence bacteria multicellular parasites, while <br />   anti-microbial properties activation                  intermediates like 5,6-dihydroxyindole shown be <br />   PO cascade provides defence arboviruses                   cytotoxic act pathogens [29,33,34]. Studies the <br />   unclear. Using arbovirus, Semliki Forest virus,                 lepidopteran Heliothis virescens (tobacco budworm) indicate that <br />   virus activates PO cascade. By using                   haemolymph contains factors antiviral activity against <br />   recombinant Semliki Forest virus expressing inhibitor               Helicoperva zea single capsid nucleopolyhedrovirus (HzSNPV) and <br />   PO cascade, demonstrate pathway                     viruses including SINV, bioassays 5,6-dihydrox- <br />   inhibits virus spread cell culture. Moreover, inhibition            yindole rapidly inactives Autographa californica multi- <br />   pathway leads higher virus genome levels                      capsid nucleopolyhedrosis virus (AcMNPV) [35&#226;&#8364;&#8220;38]. Haemo- <br />   higher mortality infected mosquitoes. In conclusion,                   lymph melanisation Lepidoptera correlates antiviral <br />   Semliki Forest virus activates PO cascade                       activity Microplitis demolitor bracovirus (MdBV) [39], and <br />   exhibits antiviral activity added list of <br />                                                                             Lymantria dispar multicapsid nucleopolyhedrovirus [40]. Whether <br />   mosquito anti-viral defence mechanisms. <br />                                                                             arboviruses activate PO cascade mosquitoes whether <br />                                                                             products PO cascade exhibit biologically relevant antiviral <br /> upregulated displaying antiviral activities [25]. Innate          activity remains unclear, interestingly RNAi knockdown <br /> immune signalling inhibit SFV replication mosquito              PPO I mosquito Armigeres subalbatus recombinant <br /> cells [26], experiments Drosophila melanogaster suggest       SINV expressing dsRNA targeting PPO I resulted reduced <br /> replication SINV inhibited IMD pathway [27].                   PO activity higher SINV titres [41]. <br />  <br />  <br />  <br />  <br /> Figure 1. Viruses used study. (A) SFV (prototype strain SFV4). (B) SFV(3H)-FFLuc-Egf1.0F SFV(3H)-FFLuc-Egf1.0R, encoding Firefly luciferase <br /> (FFLuc) non-structural polyprotein (inserted duplicated nsP2 cleavage sites nsP3/4 junction), duplicated <br /> subgenomic promoter melanisation inhibitor Egf1.0 sense (F virus; top) (as negative control) antisense orientation (R virus; bottom). (C) <br /> SFV(3F)-ZsGreen-Egf1.0F SFV(3F)-ZsGreen-Egf1.0R, expressing ZsGreen inserted C-terminal region nsP3, duplicated <br /> subgenomic promoter melanisation inhibitor Egf1.0 sense (F virus; top) (as negative control) antisense orientation (R virus; bottom). <br /> doi:10.1371/journal.ppat.1002977.g001 <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                  2                     November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                        PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />    Previous studies Aedes albopictus-derived U4.4 cells          Expression Egf1.0 SFV inhibits PO activity U4.4 <br /> have functional antiviral RNAi response immune signalling            cell-conditioned medium <br /> pathways [26,42]. Here conditioned medium                   As previously noted, PO cascade consists multiple <br /> U4.4 cells contains inducible PO activity activated             proteases terminate zymogen PPO [28&#226;&#8364;&#8220;32] (Fig. 3A). <br /> exposure bacteria purified SFV particles. Expression         The number proteolytic steps cascade fully <br /> PO cascade inhibitor Egf1.0 MdBV [39,43] SFV                       characterised insect including mosquitoes. However, is <br /> decreased PO activity U4.4 cell conditioned medium                  known infection, wounding, challenges trigger <br /> enhanced spread virus cell cultures. Infection Ae.       activation upstream serine proteases, result processing <br /> aegypti mosquitoes SFV expressing Egf1.0 resulted                  proPAPs (also referred pro-PPAEs pro-PPAFs) between <br /> enhanced viral replication mosquito mortality. Taken                   clip protease domains. Activated PAPs process PPO <br /> together, results establish role PO cascade               cleavage conserved arginine-phenylalanine (R-F) site the <br /> mosquito immune defence arbovirus.                              N-terminal domain protein, results formation of <br />                                                                            PO (Fig. 3B). PO catalyses hydroxylation monophenols like <br /> Results                                                                    tyrosine o-diphenols oxidation o-diphenols to <br />                                                                            quinones. Quinones undergo enzymatic and <br /> Immune challenge bacteria SFV increases PO                          non-enzymatic reactions produce cytotoxic intermediates and <br /> activity U4.4 cell-conditioned medium                                   ultimately melanin. Negative regulation PO cascade occurs <br />    The haemolymph mosquitoes melanises response                 endogenous protease inhibitors like serpins, while <br /> variety stimuli including wounding infection [28].                  reducing agents haemolymph like glutathione (GSH) likely <br /> Mosquitoes including Ae. aegypti encode multiple PPO genes,           inhibit melanisation reducing PO-generated quinones to <br /> some family members inducibly expressed response               diphenols [54] (Fig. 3A). Several pathogenic organisms also <br /> microbial infection [44&#226;&#8364;&#8220;47]. Haemocyte-like cell lines An.            evolved strategies suppress PO cascade hosts [28]. One of <br /> gambiae express multiple PPO genes [48], recent studies           virus MdBV, produces protein Egf1.0. <br /> identify cSP CLIPB9 candidate PAP [49].                               Functional characterization Egf1.0 showed blocks <br />    Since U4.4 cell line Ae. albopictus important            haemolymph melanisation diverse insects including mosquitoes <br /> model studying immune responses arboviruses                    activities (Fig. 3A, B). First, competitively inhibits <br /> [26,42,50], asked conditioned medium                 activated PAPs contains R-F reactive site mimics <br /> this cell line exhibited increase melanisation                  cleavage site PPO [39]. Second, Egf1.0 contains another <br /> exposure SFV bacterium Escherichia coli               domain prevents upstream proteases processing pro- <br /> well known elicitor PO cascade. Using standard                    PAPs [43]. <br /> spectrophotometric assay measuring melanisation activity                  Given background, asked Egf1.0 inhibit <br /> (see Materials Methods), results indicated PO                 increase melanisation activity occurs U4.4 cell- <br /> activity significantly increased U4.4 cell conditioned medium           conditioned medium following exposure SFV E. coli. To <br /> following exposure microbe (p = 0.003; E. coli versus              answer question, produced sets constructs. In the <br /> control, p = 0.004; SFV versus control, p = 0.021; E. coli versus          first, cloned egf1.0 gene MdBV [39] forward <br /> SFV, p = 1.00) (Fig. 2A). Our results indicated 1 h            (expressing Egf1.0 protein) reverse (negative control not <br /> incubation conditioned medium significantly reduced SFV                 expressing Egf1.0) orientation SFV control second <br /> viability relative virus incubated unconditioned medium              subgenomic promoter produce SFV4(3H)-FFLuc-Egf1.0F and <br /> (p = 0.011) (Fig. 2B).                                                     SFV4(3H)-FFLuc-Egf1.0R (Fig. 1B). These viruses expressed <br />    Because amphipathic molecules like detergents alcohol               Firefly luciferase (FFLuc), served indicator viral <br /> activate insect PPOs [51], intracellular PO activity commonly           replication spread U4.4 cell culture previously <br /> assayed PO producing cells like haemocytes fixing          shown reporter gene-expressing SFV [50] (Fig. 1B). The <br /> them methanol incubating substrate like                   second set SFV constructs expressed Egf1.0 forward or <br /> dopamine, PO utilizes produce melanin. This turn               reverse orientation second subgenomic promoter plus <br /> causes fixed cell turn black darken. In case Ae.          ZsGreen fluorescent protein inserted C-terminal region of <br /> aegypti An. gambiae, prior studies establish class         nsP3 produce SFV4(3F)-ZsGreen-Egf1.0F SFV4(3F)-ZsGreen- <br /> haemocytes, oenocytoids, constitutively exhibit intracellular PO           Egf1.0R, respectively (Fig. 1C). <br /> activity second class, granulocytes, inducibly exhibit                Next, properties SFV-expressed Egf1.0 analysed. <br /> intracellular PO activity following immune challenge                  We infected U4.4 cells SFV4(3F)-ZsGreen-Egf1.0F and <br /> bacteria [52,53]. To assess U4.4 cells exhibit intracel-           SFV4(3F)-ZsGreen-Egf1.0R multiplicity infection (MOI) of <br /> lular PO activity, fixed cells glacial methanol             10. Immunoblot analysis cell lysates confirmed each <br /> incubated buffer plus dopamine. Our results showed              recombinant virus actively replicated evidenced detection of <br /> intracellular PO activity majority cells small             nsP3-ZsGreen protein (Fig. 4A). Using anti-Egf1.0 <br /> fraction cells (0.2%) darkened manner similar mosquito            antibody, detected full-<span id='am-5' about='xsp:length' typeof='owl:Thing'>length</span> Egf1.0 [39,43] the <br /> haemocytes (Fig. 2C) [52,53]. We noted                     medium lysates prepared U4.4 cells infected with <br /> melanising cells display rounded morphology appear                   SFV4(3F)-ZsGreen-Egf1.0F did detect protein in <br /> larger U4.4 cells darken fixation         medium lysates uninfected cells cells infected with <br /> incubation substrate. We concluded assays             SFV4(3F)-ZsGreen-Egf1.0R (Fig. 4A). Our Egf1.0 antibody also <br /> that U4.4 cell-conditioned medium melanises following exposure             detected bands smaller full-length Egf1.0 in <br /> to SFV bacteria, small proportion U4.4 cells         samples infected SFV4(3F)-ZsGreen-Egf1.0F including a <br /> melanise fixation. We concluded increase                 17.6 kDa protein corresponded size C-terminal <br /> melanisation activity occurs conditioned medium corre-             Egf1.0 fragment prior studies showed produced after <br /> lates reduction SFV viability.                                   cleavage PAP (Fig. 4A). Expression Egf1.0 SFV4(3H)- <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                 3                    November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                             PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br />  <br /> Figure 2. PO activity U4.4 cell-conditioned medium. (A) PO activity conditioned medium immune challenge (Control) the <br /> addition E. coli purified SFV virions. One <span id='am-2' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> (U) PO activity defined DA490 = 0.001 30 minutes incubation (see Materials and <br /> Methods). Each bar represents mean 10 reactions; error bars standard deviation. This experiment repeated times similar <br /> results. (B) SFV virion viability 1 h incubation 28uC unconditioned culture medium medium conditioned U4.4 cells 48 h. Viability <br /> was determined titration SFV BHK-21 cells. PFU: plaque forming units. Each bar represents mean triplicate incubations; error <br /> bars standard deviation. This experiment repeated times similar results. (C) Staining intracellular PO activity U4.4 cells. <br /> Arrow indicates U4.4 cell melanised fixation incubation PO substrate dopamine. Note larger size cell its <br /> rounded morphology relative surrounding cells melanised. <br /> doi:10.1371/journal.ppat.1002977.g002 <br />  <br /> FFLuc-Egf1.0F absence Egf1.0 expression SFV4(3H)-                    control cells (p = 0.025) (Fig. 4B). Conditioned medium U4.4 <br /> FFLuc-Egf1.0R verified immunoblotting (not shown).                cells infected SFV4(3H)-FFLuc-Egf1.0F contained <br />    We analyzed functional properties SFV-expressed                 significantly (75%) PO activity medium cells <br /> Egf1.0 conditioned medium U4.4 cells. Melanisation                     infected control virus SFV4(3H)-FFLuc-Egf1.0R (p,0.001) <br /> assays 48 h post-infection (p.i.) showed conditioned                   (Fig. 4B). The addition E. coli medium SFV- infected <br /> medium cells infected SFV4(3H)-FFLuc-Egf1.0F exhib-                  cells effect PO activity (p = 0.251). As shown in <br /> ited low PO activity, similar                      Fig. 4B, addition E. coli medium SFV4(3H)-FFLuc- <br /> significantly different conditioned medium uninfected                  Egf1.0F-infected cells did increase PO activity be <br /> (control) U4.4 cells (p = 1.0) (Fig. 4B). In contrast, medium             expected Egf1.0 inhibiting PAP activity. Addition E. coli <br /> cells infected SFV4(3H)-FFLuc-Egf1.0R exhibited PO activity               medium SFV4(3H)-FFLuc-Egf1.0R-infected cells did <br /> levels significantly higher medium uninfected              elevate PO activity elevated level activity that <br />  <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                     4                     November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                            PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br />  <br /> Figure 3. Activation inhibition melanisation pathway. (A) Schematic showing insect PO cascade known mode of <br /> action Egf1.0. Infection different pathogens external wounding trigger activation PO cascade. Proteins haemolymph <br /> known humoral pattern recognition receptors (PRRs) bind factors surface different pathogens. This interaction external <br /> wounding trigger activation multiple serine proteases. Some proteases identified different insect species, others <br /> remain unknown. Activation proteases leads activation prophenoloxidase activating proteases (proPAPs PAPs). Some PAPs also <br /> require serine protease homologs (SPHs) function, activated upstream serine proteases. PAPs cleave proPO (also called <br /> PPO) PO, oxidizes mono- diphenolic substrates quinones undergo reactions form melanin. A number these <br /> intermediate products cytotoxic including shown inactivate viruses (see Text). Serine protease inhibitors called <br /> serpins identified different species insects inhibit PAPs proteases pathway. In absence wounding or <br /> infection, reducing agent glutathione (GSH) exists haemolymph concentrations inhibit melanisation recycling quinones to <br /> diphenols. The inhibitor Egf1.0 MdBV inhibits processing proPAPs PAPs activated. (B) Alignment the <br /> reactive site loop Egf1.0 predicted cleavage sites PPOs encoded Ae. aegypti (indicated AedAePPO). Note identical P1&#226;&#8364;&#8220;P19 <br /> residues R-F (underlined) Egf1.0 PPO family members. Black highlighting indicates identical residues. UniProt database identifiers in <br /> parentheses left alignment. <br /> doi:10.1371/journal.ppat.1002977.g003 <br />  <br />  <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                    5                     November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                              PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br />  <br /> Figure 4. Recombinant SFV expresses Egf1.0 inhibits PO activity U4.4 cell-conditioned medium. (A) Immunoblots showing <br /> Egf1.0 expression secretion mosquito cells. U4.4 cells infected SFV4(3F)-ZsGreen-Egf1.0F SFV4(3F)-ZsGreen-Egf1.0R MOI of <br /> 10 followed preparation cell lysate medium samples 48 h p.i. indicated Materials Methods. The left blot probed an <br /> anti-SFV nsP3 antibody individual lanes labeled follows: U4.4 cells infected SFV4(3F)-ZsGreen-Egf1.0R (R = cell lysate, Rm = conditioned <br /> medium), U4.4 cells infected SFV4(3F)-ZsGreen-Egf1.0F (F = cell lysate, Fm = conditioned medium), uninfected cells (U = cell lysate, <br /> Um = conditioned medium). Black star identifies nsP3-ZsGreen protein, detected lysates SFV-infected cells. Black diamond indicates <br /> bovine serum albumin (non-specifically detected high abundance). The right blot shows samples probed anti-Egf1.0 <br /> antibody. A control lane (C) added blot (purified, recombinant Egf1.0). Note Egf1.0 detected control lane, F Fm <br /> lanes. Black arrow indicates uncut Egf1.0; open arrow identifies band corresponding predicted C-terminal domain Egf1.0 PAP <br /> cleavage. Molecular mass markers indicated left. (B) PO activity conditioned medium uninfected U4.4 cells (Control), cells infected with <br /> SFV4(3H)-FFLuc-Egf1.0F (Egf1.0F), SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R), cells infected SFV4(3H)-FFLuc-Egf1.0F E. coli added medium <br /> (Egf1.0F+E. coli), cells infected SFV4(3H)-FFLuc-Egf1.0R E. coli added medium (Egf1.0R+E. coli), medium uninfected cells E. <br /> coli added (E. coli). PO activity measured outlined Fig. 2A; 1 ml conditioned medium taken 48 h p.i. 2.66105 U4.4 cells <br /> infected MOI 10, uninfected (Control). Each bar represents mean 10 reactions; error bars standard deviation. This <br /> experiment repeated times similar results. <br /> doi:10.1371/journal.ppat.1002977.g004 <br />  <br />  <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                     6                      November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                        PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br /> already existed. Taken together, results showed                 formed PO, infected U4.4 cells low MOI of <br /> SFV4(3H)-FFLuc-Egf1.0F produced Egf1.0 U4.4 cells,                SFV4(3H)-FFLuc-Egf1.0R (MOI 0.005) added GSH <br /> is secreted medium. Given prior evidence Egf1.0              (0.5 mM), noted likely inhibits melanisation by <br /> specifically inhibits PO cascade disabling PAP function,            reducing quinones (see Fig. 3A) [54]. Our results showed that <br /> these data strongly suggested U4.4 cell-conditioned              GSH significantly increased spread SFV4-FFLuc-Egf1.0R <br /> medium contains functional PO cascade, activated             relative medium added GSH (p,0.001). As expected <br /> SFV gram-negative bacteria, inhibited SFV-              though, addition GSH did change rate spread of <br /> produced Egf1.0.                                                           SFV4(3H)-FFLuc-Egf1.0F (p = 0.139) (Fig. 6A). <br />                                                                                 Although vertebrates lack PO cascade, tested whether <br /> The inhibitor Egf1.0 enhances SFV spread U4.4                      expression Egf1.0 conferred replicative advantage SFV in <br /> cell culture                                                               BHK-21 cells. There significant difference spread of <br />    We asked inhibition PO activity Egf1.0               SFV4(3H)-FFLuc-Egf1.0F SFV4(3H)-FFLuc-Egf1.0R (p = 0.64) <br /> could enhance virus spread infection. We used          following low MOI infection (0.005), indicating Egf1.0 no <br /> SFV4(3H)-FFLuc-Egf1.0F SFV4(3H)-FFLuc-Egf1.0R constructs                effect dissemination SFV mammalian cell line (Fig. 6B). <br /> which allowed monitor viral replication spread a <br /> U4.4 cell culture measuring FFluc activity 24 h 48 h p.i.,       PO activity protects mosquitoes following SFV infection <br /> similar previously described experiments [50]. Infections              Immunologically important antiviral pathways mosquitoes <br /> carried high multiplicity infection (MOI 10),           RNAi previously implicated promoting <br /> where U4.4 cells infected little spread        mosquito <span id='am-7' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-8' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-11' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-40' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-51' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-70' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span>survival</span> arbovirus infection. Indeed, inhibition of <br /> of virus occur, low MOI (0.005) small              RNAi pathway alphavirus-expressed RNAi inhibitors <br /> fraction cells initially infected SFV         results rapid death virus-infected mosquitoes [55,56]. To test <br /> disseminate medium infect cells. Overall              PO cascade provides effective antiviral defence in <br /> GLM revealed differences FFLuc activity function MOI            mosquitoes, extended experiments Ae. aegypti, mosquito <br /> (10 0.005), construct (SFV4(3H)-FFLuc-Egf1.0F SFV4(3H)-              species generally relevant arbovirus vector, which <br /> FFLuc-Egf1.0R) sample time (24 h 48 h p.i.) (Fig. 5 A&amp;B,            shown transmit SFV laboratory [57&#226;&#8364;&#8220;59]. <br /> p = 0.012). As result data high low MOI                 Prior studies implicate Ae. aegypti alongside Ae. africanus a <br /> treatments examined separately.                                       natural vector SFV [60]. Ae. aegypti fed bloodmeals <br />    At MOI 10, cells infected SFV4(3H)-FFLuc-Egf1.0F             containing SFV4(3H)-FFLuc-Egf1.0F, SFV4(3H)-FFLuc-Egf1.0R, <br /> or SFV4(3H)-FFLuc-Egf1.0R exhibited similar levels FFluc                virus (mock-infection). We monitored mosquito survival <br /> activity 24 h 48 h p.i. (p = 0.74) (Fig. 5A). This outcome       (cohorts 22&#226;&#8364;&#8220;25 mosquitoes) following infection three <br /> fully consistent cells infected containing             independent experiments determine survival rates (Fig. 7A). <br /> actively replicating SFV, indicating Egf1.0         Since significant differences detected treatments in <br /> effect intracellular replication activity. As expected, rates        experiments (p.0.05), samples pooled for <br /> replication dropped low levels recombinant viruses        analysis. Overall, mosquito survival differed significantly <br /> at 48 h p.i. (p,0.001) entered persistent phase of <br />                                                                            treatments (Kaplan Meier x2 = 25.37; p,0.001). Post Hoc <br /> infection [26] (Fig. 5A). In contrast, observed different <br />                                                                            multiple comparison tests revealed significant difference in <br /> outcome cells infected low MOI FFluc <br />                                                                            survival rates mock-infected control mosquitoes <br /> activity differed cells infected SFV4(3H)-FFLuc- <br />                                                                            infected SFV4(3H)-FFLuc-Egf1.0R (p = 0.98). In contrast, <br /> Egf1.0F SFV4(3H)-FFLuc-Egf1.0R. At 24 h p.i, no <br />                                                                            mosquitoes infected SFV4(3H)-FFLuc-Egf1.0F exhibited <br /> difference FFLuc activity cells infected SFV4(3H)- <br />                                                                            higher mortality mock-infected mosquitoes (p,0.001) or <br /> FFLuc-Egf1.0F SFV4(3H)-FFLuc-Egf1.0R (p = 0.37), at <br />                                                                            mosquitoes infected SFV4(3H)-FFLuc-Egf1.0R (p,0.001). In <br /> 48 h p.i. SFV4(3H)-FFLuc-Egf1.0F showed significantly higher <br /> spread replication rates SFV4(3H)-FFLuc-Egf1.0R                   conclusion, inhibition PO cascade decreased survival <br /> (p = 0.004) (Fig. 5A). We reasoned difference           following infection mosquitoes SFV. <br /> most likely linked time required Egf1.0 expressed             To assess reduced survival SFV4(3H)-FFLuc- <br /> and secreted, infectious SFV produced.                           Egf1.0F-infected mosquitoes associated enhanced viral <br />    Repeating experiments using SFV4(3F)-ZsGreen-Egf1.0F              replication, mosquitoes (cohorts 10) fed bloodmeals <br /> and SFV4(3F)-ZsGreen-Egf1.0R allowed visualize virus spread          containing SFV4(3H)-FFLuc-Egf1.0F SFV4(3H)-FFLuc- <br /> <span id='am-4' about='protege:FROM' typeof='owl:Thing'>from</span> cell green fluorescing foci           Egf1.0R. Total RNA extracted 3 days post- <br /> form ZsGreen presence viral replication complexes                  bloodmeal followed qPCR analysis determine SFV genome <br /> (ZsGreen inserted C-terminal region nsP3; Fig. 1C).         copy number individual. This time point chosen because <br /> At high MOI 10, U4.4 cells contained green foci 48 h          just precedes quantifiable differences mosquito survival, thus <br /> when infected SFV4(3F)-ZsGreen-Egf1.0F SFV4(3F)-                   avoiding mortality-induced bias. Our results showed viral <br /> ZsGreen-Egf1.0R (Fig. 5B). At low MOI 0.005, however,                 genome copy numbers higher mosquitoes fed SFV4(3H)- <br /> more cells exhibited green foci 48 h p.i. infected            FFLuc-Egf1.0F mosquitoes fed SFV4(3H)-FFLuc-Egf1.0R <br /> SFV4(3F)-ZsGreen-Egf1.0F              SFV4(3F)-ZsGreen-Egf1.0R        (Mann-Whitney test, p = 0.04) (Fig. 7B). Interestingly, infection <br /> (Fig. 5B).                                                                 rates higher mosquitoes infected <br />    Overall, data strongly suggested activation PO        SFV4(3H)-FFLuc-Egf1.0F SFV4(3H)-FFLuc-Egf1.0R <br /> cascade SFV reduced virus spread, Egf1.0 enhances               (Fig. 7B). This suggests Egf1.0-mediated inhibition the <br /> virus spread inhibiting PO cascade. However, results          PO cascade potentially important establishment an <br /> did provide insight identity effector              infection. Higher infection rates previously observed <br /> molecules produced PO cascade reduce SFV viability             alphaviruses expressing RNAi inhibitors following <br /> and spread. To assess anti-SFV effects PO          silencing antiviral RNAi genes mosquito infection <br /> to formation reactive intermediates products               [55,61]. <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                 7                    November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                           PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br />  <br /> Figure 5. Inhibition PO activity enhances spread SFV U4.4 cells. (A) U4.4 cells infected SFV4(3H)-FFLuc-Egf1.0F <br /> (Egf1.0F) SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R) MOI 10 (left graph) 0.005 (right graph). FFLuc activity (expressed lights units) was <br /> determined 24 48 h p.i. Each bar represents mean triplicate cultures; error bars standard deviation. This experiment repeated <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                   8                     November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                              PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br /> three times similar results. (B) Epifluorescent micrographs U4.4 cells 48 h p.i. SFV4(3F)-ZsGreen-Egf1.0F MOI 10 (P1), SFV4(3F)- <br /> ZsGreen-Egf1.0F MOI 0.005 (P3), SFV4(3F)-ZsGreen-Egf1.0R MOI 10 (P2), SFV4(3F)-ZsGreen-Egf1.0R MOI 0.005 (P4). Arrows <br /> point ZsGreen-positive replication foci cytoplasm selected U4.4 cells. Cell nuclei counterstained marker TOPRO3. Note low MOI <br /> infection increased number replication foci cells infected SFV4(3F)-ZsGreen-Egf1.0F (P3) relative cells infected SFV4(3F)-ZsGreen- <br /> Egf1.0R (P4). This experiment repeated times similar results. <br /> doi:10.1371/journal.ppat.1002977.g005 <br />  <br />  <br /> Discussion                                                                     activation Toll pathway, depletion Serpin-1 leads <br />                                                                                immune responses parasite Plasmodium gallinaceum <br />    Comparative genome analysis different mosquito species                   [62]. Other regulators melanisation Ae. aegypti CLSP2 <br /> reveals noticeable expansion PPO genes relative                  (a modular protein consisting C-type lectin elastase-like <br /> insects. For example, An. gambiae encodes PPOs Ae.                  domains) described [63]. Transcription some <br /> aegypti encodes ten. Expansion numbers clip-domain                   PPO genes Ae. aegypti regulated Toll pathway [44], <br /> serine proteases serpins occurred [47]. The recent                linking different branches immune response. <br /> sequencing Culex quinquefasciatus genome reveals PPOs                 Based antiviral activities insect haemolymph [35,36], <br /> and thirty-two serpins, compared originally twenty-three serpins            hypothesized immune reactions induced PO extend to <br /> in Ae. aegypti recent studies Vectorbase increase              arboviral infection mosquitoes. Our experiments collectively <br /> number twenty-six [45&#226;&#8364;&#8220;47,62]. Compared insects                     indicate U4.4 cell-conditioned medium contains functional <br /> including An. gambiae, relatively little known regulation          PO cascade. Our detection small proportion U4.4 cells that <br /> the PO cascade mosquitoes recent studies Ae. aegypti            melanise fixation incubation dopamine further <br /> identify processes involved [62]. Interestingly cSP            suggest cells likely source PO activity detected in <br /> family contains proteins non-catalytic protease domain,              conditioned medium. Notably, cells morphologically resem- <br /> so-called clip domain serine protease homologs (cSPHs),               ble oenocytoids, comprise 1% the <br /> cSPs cSPHs (as co-factors) involved melanisation                    circulating haemocyte population mosquitoes like Ae. aegypti <br /> reactions.                                                                     An. gambiae [52,53] insects, also <br />    In Ae. aegypti An. gambiae, cSPs cSPHs divided             primary source PO plasma [51]. Ongoing analysis the <br /> five subfamilies called CLIP A, B, C, D E [47]. Mainly CLIP                U4.4 cell transcriptome indicates PPO orthologs are <br /> B subfamily proteases known (or suggested) activate PPOs.               expressed time remains unclear whether <br /> Melanisation Ae. aegypti regulated protease              expression restricted large, rounded cells stain after <br /> inhibitor Serpins-1, -2 -3 regulate different cSPs [62].             incubation dopamine global. Regardless these <br /> In study, separate pathways leading PPO cleavage                   uncertainties, results strongly indicate medium condi- <br /> were described; pathway linking Serpin-1 (CLIP B                    tioned U4.4 cells contains functional PO cascade is <br /> subfamily members) Immune melanisation protease (IMP)-1                    activated exposure SFV E. coli, inhibited Egf1.0. <br /> IMP-2, second pathway linking Serpin-2 Tissue                         Prior studies Lepidoptera MdBV activates the <br /> melanisation protease (TMP) IMP-1. Depletion Serpin-2                   PO cascade [39] bacterial cell wall components like <br /> leads tissue melanisation appears involved                     peptidoglycan known activators PO cascade a <br />  <br />  <br />  <br />  <br /> Figure 6. Spread SFV mosquito vertebrate cells. (A) The addition glutathione (GSH) medium enhances spread SFV. U4.4 <br /> cells infected SFV4(3H)-FFLuc-Egf1.0F (Egf1.0F) SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R) MOI 0.005 followed determination FFLuc <br /> activity 48 h p.i. + GSH: 0.5 mM GSH; 2 GSH: negative control. Each bar represents mean triplicate cultures; error bars standard <br /> deviation. This experiment repeated times similar results. (B) Egf1.0 effect SFV spread BHK-21 cells. Cells infected <br /> with SFV4(3H)-FFLuc-Egf1.0F (Egf1.0F) SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R) MOI 0.005 followed determination FFLuc activity 24 h and <br /> 48 h p.i. Each bar represents mean triplicate cultures; error bars standard deviation. This experiment repeated times with <br /> similar results. <br /> doi:10.1371/journal.ppat.1002977.g006 <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                     9                      November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                       PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br />  <br /> Figure 7. Expression Egf1.0 increases mortality Ae. aegypti replication SFV vivo. (A) Ae. aegypti fed blood containing <br /> SFV4(3H)-FFLuc-Egf1.0F SFV4(3H)-FFLuc-Egf1.0R. Uninfected blood meals served control. Mosquito mortality monitored daily post- <br /> bloodmeal. Combined survival data independent experiments (cohorts 22&#226;&#8364;&#8220;25 infected mosquitoes virus control mosquitoes in <br /> each experiment) shown. Error bars standard deviation. (B) SFV genome copy number determined real time qPCR. Total RNA was <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                10                   November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                            PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br /> extracted 3 days post-bloodmeal mosquitoes infected SFV4(3H)-FFLuc-Egf1.0F SFV4(3H)-FFLuc-Egf1.0R. Viral genome RNA levels 10 <br /> mosquitoes virus shown. Values 0 represent uninfected mosquitoes. Horizontal bar indicates average genome copy number from <br /> infected mosquitoes. This experiment repeated times similar results. <br /> doi:10.1371/journal.ppat.1002977.g007 <br />  <br /> diversity insects [28&#226;&#8364;&#8220;32]. We think likely activation        integrity SFV virions [38]. Any damage structural proteins <br /> PO cascade U4.4 cell-conditioned medium E. coli similarly                result failure bind receptors and/or enter cells. <br /> involves binding bacterial cell wall components currently                Questions remain tissue specificity PO activity. <br /> unknown humoral pattern recognition receptors. In contrast,                 Our vitro vivo data overall suggest products PO <br /> remains unclear features SFV induce similar increase              cascade antiviral reduce viability of <br /> PO activity. One possibility glycoproteins viral                virions haemocoel. However research describes <br /> envelope function pathogen-associated molecular patterns. The               melanisation reactions extracellular space An. <br /> lectin pathway vertebrate complement known activated               gambiae midgut cells following Plasmodium berghei infection [66]. <br /> by pattern recognition receptors mannose&#226;&#8364;&#8220;binding lectin                Thus inhibition PO activity Egf1.0 enhance SFV <br /> that binds mannose-containing glycoproteins [64]. Several lectins              replication spread midgut tissues. Finally, our <br /> have described candidate pattern recognition                      study does directly address question wild-type <br /> receptors insects [65].                                                     SFV potentially inhibit evade PO response. Given <br />    While additional studies needed identify SFV              SFV spread enhanced expression powerful <br /> being recognised U4.4 cell conditioned medium, results                  inhibitor like Egf1.0, suspect ability wild-type SFV to <br /> collectively indicate activation PO cascade                inhibit evade host-associated PO defence response likely <br /> associated increase melanisation occurs reduces spread             weak. <br /> of SFV U4.4 cell population. Reduced survival Ae.                    Alphaviruses inhibited Toll pathway insects <br /> aegypti combined enhanced virus replication mosquitoes               [26,27], links PO cascade Toll signalling in <br /> are infected SFV expressing Egf1.0 suggests PO                     Ae. aegypti could, noted above, play role antiviral defence. <br /> cascade important limiting arbovirus spread mosquitoes.               Infection Ae. aegypti DENV-2 results differential <br /> Interestingly, gene expression data obtained following ONNV                    regulation serpins possible speculate <br /> infection An. gambiae indirectly suggest ONNV infection                role controlling PPO activation [24]. It <br /> may led activation melanisation pathways early               does suggest protease-mediated antiviral defences <br /> stages infection [25], highlights importance              extend arbovirus families. Intriguingly, shown <br /> study.                                                                         infection insects strains endosymbyotic Wolbachia <br />    On hand, effects PO cascade inhibition                  bacteria, inhibit arbovirus infection unknown <br /> mosquito survival apparent later stages post-bloodmeal             mechanisms [67], upregulate melanisation genes involved <br /> compared experiments alphaviruses expressing RNAi                      melanisation [68,69]. Thus, findings explain in <br /> inhibitors [55,56]. This suggests inhibition PO cascade            antiviral properties mediated Wolbachia infection. <br /> takes time disruption RNAi response               Future work determine findings extend to <br /> less powerful RNAi defence arboviruses. However                viruses arbovirus families. <br /> these experiments viral expression inhibitor a <br /> viable strategy inhibiting insect immune responses. Expression             Materials Methods <br /> from subgenomic promoter recombinant SFV results in <br /> high levels Egf1.0 strong inhibitory activity,             Ethics statement <br /> difficult achieve just silencing target gene RNAi.               Under UK Home Office legislation insects mosquitoes <br /> Thus, important goal future studies assess               considered animals. No animals used course of <br /> inhibition PO cascade affects spread SFV different            experiments. Defibrinated sheep blood obtained from <br /> tissues mosquitoes PO cascade interact               TCS Biosciences (Buckingham, United Kingdom). <br /> with immune defence responses including RNAi <br /> pathway.                                                                       Cells, viruses infection <br />    Previous experiments PPO I silenced Ar. subalbatus                Ae. albopictus-derived U4.4 mosquito cells grown 28uC in <br /> by expression PPO I dsRNA using recombinant SINV showed                     L-15 medium 10% fetal calf serum 10% tryptose <br /> increased titres SINV [41]. Our results observation               phosphate broth. BHK-21 cells grown Glasgow minimum <br /> further showing activation PO cascade reduces SFV               essential medium (GMEM) 10% newborn calf serum and <br /> viability vitro Egf1.0-mediated inhibition enhances virus          10% tryptose phosphate broth 37uC 5% CO2 atmosphere. <br /> replication spread vitro vivo. However            Amplification SFV (strain SFV4) recombinant clones <br /> entirely clear products generated PO cascade                   derived SFV4 BHK-21 cells (grown described above), <br /> responsible antiviral activity SFV observe.                 titration plaque forming units (PFU) BHK-21 <br /> Given antiviral properties 5,6-dihydroxyindole                  cells previously described [50]. SFV derived clones <br /> AcMNPV [38], ability GSH inhibit anti-SFV activity               purified supernatant described resuspended in <br /> in conditioned U4.4 cell culture medium suggests reactive             TNE (Tris-NaCl-EDTA) buffer [70]. Viruses diluted in <br /> intermediates generated PO antiviral. However,               PBSA (PBS 0.75% bovine serum albumin) added U4.4 <br /> possible PO cascade reduce arbovirus spread                 cells room temperature 1 h followed washing twice to <br /> initial site infection production melanin and/or             remove unbound particles; cells grown 28uC following <br /> activation signaling pathways like Toll IMD              infection. Details reporter viruses (Fig. 1) obtained from <br /> have roles antiviral defence. To distinguish                  authors. The pCMV-SFV4 backbone production SFV4 <br /> possibilities require studies directly assess effects         previously described [71]. A second subgenomic <br /> 5,6-dihydroxyindole, melanin, compounds                        promoter placed SFV4 structural open reading <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                    11                    November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                                PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br /> frame construction viruses duplicated subgenomic                      50 mM Sodium Phosphate buffer (pH 6.5) containing 2 mM <br /> promoters [72]. This second subgenomic promoter T37/                    dopamine added 20 ml cell culture medium [75]. PO activity <br /> 17 type (consisting sequence 37 nucleotides upstream 17                  monitored measuring absorbance 490 nm using plate <br /> nucleotides downstream original transcription start-site                reader (Dynatech MR5000) period 30 min. It be <br /> the SFV subgenomic mRNA). The ZsGreen marker inserted                         noted approach predominantly detects dopachrome and/ <br /> into C-terminal region nsP3 XhoI site naturally                      dopaminechrome melanin itself. One <span id='am-3' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> PO <br /> occuring genomic sequence (leading expression nsP3                   activity defined DA490 = 0.001 30 minutes, similar to <br /> containing ZsGreen), Firefly luciferase (FFLuc) inserted                previously described [39,76,77]. For experimental condition, <br /> between duplicated nsP2 cleavage sites nsP3/4 junction                PO activities 10 reactions determined. Intracellular PO <br /> cleavable reporter, using strategies previously shown [73]. The              activity assessed fixing U4.4 cells glacial methanol. <br /> egf1.0 coding sequence (including signal peptide) derived                    After rinsing PBS, fixed cells incubated 1 h in <br /> MdBV placed control second subgenomic                            phosphate buffer plus 2 mM dopamine. <br /> promoter sense antisense (as negative control) orientation. <br />                                                                                   Determination luciferase activities <br /> Detection ZsGreen expression                                                      Following cell lysis Passive Lysis Buffer (Promega), luciferase <br />    Cells glass slides fixed 10% formaldehyde (Fisher                   activities determined using Dual Luciferase assay kit <br /> Chemicals) 45 min washed PBS times. Cells                   (Promega) GloMax 20/20 luminometer. <br /> treated TO-PRO 3 (Invitrogen) (1:1000) dH2O 10 min <br /> and washed PBS times. Slides mounted using                        Real time quantitative PCR analysis (qPCR) <br /> Vectashield mounting medium (Vector Laboratories). Cells                         SFV4 genome copy number quantified previously <br /> fluorescence visualised confocal microscopy.                         described [26]. Briefly, total RNA isolated single Ae. <br />                                                                                   aegypti using Trizol (Invitrogen). RNA quality quantity were <br /> Detection Egf1.0 immunoblotting                                             assessed NanoDrop 1000 spectrophotometer (Fisher <br />     At 48 h p.i., U4.4 cells infected SFV (MOI 10) control             Scientific). A total 0.5 mg total RNA mosquito was <br /> uninfected cells lysed Laemmli buffer. Conditioned cell                   reverse transcribed using Superscript III kit (Invitrogen) oligo- <br /> culture medium concentrated Millipore Centricon-Plus 70                    dT primer, reactions analysed triplicate. The reaction <br /> Centrifugal Filter Units prior addition Laemmli buffer.                     mix contained 0.8 mM primer, FastStart SYBR Green <br /> Recombinant Egf1.0 produced previously described [39] served                   Master x1 (Roche), 2 ml template. Tubes heated to <br /> as positive control. Samples run 4&#226;&#8364;&#8220;20% Tris-Gycine                    94uC 5 min, cycled 94uC 20 sec, 62uC <br /> PAGEr precast gels (Lonza), blotted Immobilon-P PVDF                     20 sec, 72uC 20 sec 40 cycles RotorGene 3000 <br /> membranes (Millipore). SFV infection detected using rabbit                  instrument (Corbett Research). Sequences primers as <br /> anti-nsP3 antibody (1:20000), Egf1.0 detected using                   indicated: 59 -GCAAGAGGCAAACGAACAGA-39 (SFV-nsP3- <br /> rabbit anti-Egf1.0 antibody (1:35000) [39,74]. Primary antibodies                 for) 59 &#226;&#8364;&#8220;GGGAAAAGATGAGCAAACCA-39 (SFV-nsP3- <br /> were detected using horseradish peroxidase (HRP)-conjugated goat-               rev). The number SFV genome copies calculated using a <br /> anti rabbit secondary antibody (Jackson ImmunoResearch) (1:45000),                standard curve generated plasmid pSFV1. <br /> followed visualisation using ECL Advance Western Blotting <br /> Kit (Amersham) GeneGnome bioimaging (Syngene).                       Statistical analysis <br />                                                                                      Data 2 groups analysed using t-test Mann <br /> Mosquito rearing infection                                                    Whitney tests, depending structure data. Data with <br />     Aedes aegypti (Liverpool red eye strain optimised filarial growth)        2 groups analysed using General Linear Models <br /> were kindly provided R. M. Maizels Y. Harcus (Institute                 (GLM). All GLMs initially performed including fixed <br /> Immunology Infection Research, University Edinburgh).                      effects interactions. Any post hoc tests adjusted for <br /> Mosquitoes kept 27uC, 85% humidity 16 h                     multiple comparisons using Bonferroni correction. Survival <br /> light: 8 h dark photoperiod. Larvae fed standard yeast                  analysis performed cohorts 22&#226;&#8364;&#8220;25 mosquitoes. <br /> diet, adults fed 10% fructose continuously. Female                  Differences survivorship curves tested using <br /> adults 4 5 days old allowed feed defibrinated                  Kaplan-Meier estimator log-rank test. Where appropriate, <br /> sheep blood (TCS Biosciences) containing 56107 PFU virus                   multiple comparisons performed Bonferroni <br /> ml blood supplemented 4 mM ATP. Mosquitoes                           correction applied. All analyses conducted using SAS <br /> starved 24 h feeding bloodmeal (at 37uC)                       v9.1.3 (SAS Institute Inc., Cary, NC, USA). Diagnostics were <br /> provided Hemotek membrane feeder (Discovery Workshops,                       performed plots residuals examined, confirming the <br /> Accrington, UK) 2 h. Mosquitoes fed removed                     goodness-of-fit models. Prior analysis, specified that <br /> maintained standard conditions fructose.                                  results p,0.05 reported exhibiting formal <br />                                                                                   statistical significance. <br /> Melanisation assays determination PO activity <br />    Conditioned cell culture medium Ae. albopictus-derived U4.4               Acknowledgments <br /> mosquito cells harvested 48 h post-cell seeding (46106 cells             We thank Prof. R. M. Maizels Dr. Y. Harcus (Institute Immunology <br /> 75 cm2 flask) centrifuged 2000 rpm 5 min order                   Infection Research, University Edinburgh, UK) mosquitoes. <br /> eliminate residual cells. Approximately 5 ml pelleted E. coli <br /> JM109 culture (New England Biolabs) 3.56107 PFU SFV                         Author Contributions <br /> were added 1 ml cell culture medium incubated                       Conceived designed experiments: JRA MRS JKF AK. Performed <br /> 10 min room temperature. The mixture centrifuged                   experiments: JRA SR MV MHB MCF RF ES GB. Analyzed data: <br /> 3000 rpm 10 min 4uC order remove debris. Following                   JRA MECT MHB MRS JKF AK. Contributed reagents/materials/ <br /> this, PO activity assays carried 96-well plates 100 ul           analysis tools: MRS AM. Wrote paper: AK MRS JRA JKF. <br />  <br />  <br />  <br /> PLOS Pathogens | www.plospathogens.org                                       12                     November 2012 | Volume 8 | Issue 11 | e1002977 <br />                                                                                                                                 PO-Mediated Antiviral Activity Against SFV <br />  <br />  <br />  <br />  <br /> References <br />  1. Weaver SC (2006) Evolutionary influences arboviral disease. Curr Top                  34. Beerntsen BT, James AA, Christensen BM (2000) Genetics mosquito vector <br />     Microbiol Immunol 299: 285&#226;&#8364;&#8220;314.                                                              competence. Microbiol Mol Biol Rev 64: 115&#226;&#8364;&#8220;137. <br />  2. Weaver SC, Barrett AD (2004) Transmission cycles, host range, evolution              35. Popham HJ, Shelby KS, Brandt SL, Coudron TA (2004) Potent virucidal <br />     emergence arboviral disease. Nat Rev Microbiol 2: 789&#226;&#8364;&#8220;801.                                activity larval Heliothis virescens plasma Helicoverpa zea single capsid <br />  3. Halstead SB (2007) Dengue. Lancet 370: 1644&#226;&#8364;&#8220;1652.                                            nucleopolyhedrovirus. J Gen Virol 85: 2255&#226;&#8364;&#8220;2261. <br />  4. Weaver SC, Reisen WK (2010) Present future arboviral threats. Antiviral              36. Shelby KS, Popham HJ (2006) Plasma phenoloxidase larval tobacco <br />     Res 85: 328&#226;&#8364;&#8220;345.                                                                             budworm, Heliothis virescens, virucidal. J Insect Sci 6: 1&#226;&#8364;&#8220;12. <br />  5. Gould EA, Coutard B, Malet H, Morin B, Jamal S, et al. (2010) Understanding              37. Ourth DD, Renis HE (1993) Antiviral melanization reaction Heliothis <br />     alphaviruses: Recent research important emerging pathogens                        virescens hemolymph DNA RNA viruses vitro. Comp Biochem <br />     progress control. Antiviral Res 87: 111&#226;&#8364;&#8220;124.                                   Physiol B 105: 719&#226;&#8364;&#8220;723. <br />  6. Strauss JH, Strauss EG (1994) The alphaviruses: gene expression, replication,            38. Zhao P, Lu Z, Strand MR, Jiang H (2011) Antiviral, anti-parasitic, cytotoxic <br />     evolution. Microbiol Rev 58: 491&#226;&#8364;&#8220;562.                                                    effects 5,6-dihydroxyindole (DHI), reactive compound generated by <br />  7. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT (2012) Chikungunya:                    phenoloxidase insect immune response. Insect Biochem Mol Biol 41: <br />     re-emerging virus. Lancet 379: 662&#226;&#8364;&#8220;671.                                                      645&#226;&#8364;&#8220;652. <br />  8. Salonen A, Ahola T, Kaariainen L (2005) Viral RNA replication association             39. Beck MH, Strand MR (2007) A novel polydnavirus protein inhibits insect <br />     cellular membranes. Curr Top Microbiol Immunol 285: 139&#226;&#8364;&#8220;173.                            prophenoloxidase activation pathway. Proc Natl Acad Sci U S A 104: 19267&#226;&#8364;&#8220; <br />  9. Garoff H, Sjoberg M, Cheng RH (2004) Budding alphaviruses. Virus Res                      19272. <br />     106: 103&#226;&#8364;&#8220;116.                                                                            40. McNeil J, Cox-Foster D, Slavicek J, Hoover K (2010) Contributions immune <br /> 10. Sanchez-San Martin C, Liu CY, Kielian M (2009) Dealing low pH: entry                    responses developmental resistance Lymantria dispar challenged with <br />     exit alphaviruses flaviviruses. Trends Microbiol 17: 514&#226;&#8364;&#8220;521.                     baculovirus. J Insect Physiol 56: 1167&#226;&#8364;&#8220;1177. <br /> 11. Kononchik JP, Jr., Hernandez R, Brown DT (2011) An alternative pathway               41. Tamang D, Tseng SM, Huang CY, Tsao IY, Chou SZ, et al. (2004) The use a <br />     alphavirus entry. Virol J 8: 304.                                                            double subgenomic Sindbis virus expression study mosquito gene <br /> 12. Jose J, Snyder JE, Kuhn RJ (2009) A structural functional perspective                 function: effects antisense nucleotide number duration viral infection <br />     alphavirus replication assembly. Future Microbiol 4: 837&#226;&#8364;&#8220;856.                            gene silencing efficiency. Insect Mol Biol 13: 595&#226;&#8364;&#8220;602. <br /> 13. Brown DT (1984) Alphavirus growth cultured vertebrate invertebrate                42. Siu RW, Fragkoudis R, Simmonds P, Donald CL, Chase-Topping ME, et al. <br />     cells. In: Mayo MA, K.A. Herrop, editor. Vectors Virus Biology. New York:                 (2011) Antiviral RNA Interference Responses Induced Semliki Forest Virus <br />     Academic Press. pp. 113&#226;&#8364;&#8220;133.                                                                 Infection Mosquito Cells: Characterization, Origin, Frequency- <br /> 14. Fragkoudis R, Attarzadeh-Yazdi G, Nash AA, Fazakerley JK, Kohl A (2009)                      Dependent Functions Virus-Derived Small Interfering RNAs. J Virol 85: <br />     Advances dissecting mosquito innate immune responses arbovirus infection.              2907&#226;&#8364;&#8220;2917. <br />     J Gen Virol 90: 2061&#226;&#8364;&#8220;2072.                                                               43. Lu Z, Beck MH, Wang Y, Jiang H, Strand MR (2008) The viral protein Egf1.0 <br /> 15. Sanchez-Vargas I, Travanty EA, Keene KM, Franz AW, Beaty BJ, et al. (2004)                   dual activity inhibitor prophenoloxidase-activating proteinases 1 3 <br />     RNA interference, arthropod-borne viruses, mosquitoes. Virus Res 102: 65&#226;&#8364;&#8220;                Manduca sexta. J Biol Chem 283: 21325&#226;&#8364;&#8220;21333. <br />     74.                                                                                      44. Zou Z, Shin SW, Alvarez KS, Bian G, Kokoza V, et al. (2008) Mosquito <br /> 16. Blair CD (2011) Mosquito RNAi major innate immune pathway                             RUNX4 immune regulation PPO gene expression effect on <br />     controlling arbovirus infection transmission. Future Microbiol 6: 265&#226;&#8364;&#8220;277.               avian malaria parasite infection. Proc Natl Acad Sci U S A 105: 18454&#226;&#8364;&#8220;18459. <br /> 17. Donald CL, Kohl A, Schnettler E (2012) New insights control arbovirus            45. Arensburger P, Megy K, Waterhouse RM, Abrudan J, Amedeo P, et al. (2010) <br />     replication spread insect RNA interference pathways. Insects 3: 511&#226;&#8364;&#8220;531.              Sequencing Culex quinquefasciatus establishes platform mosquito <br /> 18. Khoo CC, Piper J, Sanchez-Vargas I, Olson KE, Franz AW (2010) The RNA                        comparative genomics. Science 330: 86&#226;&#8364;&#8220;88. <br />     interference pathway affects midgut infection- escape barriers Sindbis           46. Nene V, Wortman JR, Lawson D, Haas B, Kodira C, et al. (2007) Genome <br />     virus Aedes aegypti. BMC Microbiology 10: 130.                                            sequence Aedes aegypti, major arbovirus vector. Science 316: 1718&#226;&#8364;&#8220;1723. <br /> 19. Sanchez-Vargas I, Scott JC, Poole-Smith BK, Franz AWE, Barbosa-Solomieu                  47. Waterhouse RM, Kriventseva EV, Meister S, Xi Z, Alvarez KS, et al. (2007) <br />     Vr, et al. (2009) Dengue Virus Type 2 Infections Aedes aegypti Are                        Evolutionary dynamics immune-related genes pathways disease-vector <br />     Modulated Mosquito&#226;&#8364;&#8482;s RNA Interference Pathway. PLoS Pathog 5:                         mosquitoes. Science 316: 1738&#226;&#8364;&#8220;1743. <br />     e1000299.                                                                                48. Muller HM, Dimopoulos G, Blass C, Kafatos FC (1999) A hemocyte-like cell <br /> 20. Bartholomay LC, Waterhouse RM, Mayhew GF, Campbell CL, Michel K, et al.                      line established malaria vector Anopheles gambiae expresses six <br />     (2010) Pathogenomics Culex quinquefasciatus meta-analysis infection                prophenoloxidase genes. J Biol Chem 274: 11727&#226;&#8364;&#8220;11735. <br />     responses diverse pathogens. Science 330: 88&#226;&#8364;&#8220;90.                                      49. An C, Budd A, Kanost MR, Michel K (2011) Characterization regulatory <br /> 21. Girard YA, Mayhew GF, Fuchs JF, Li H, Schneider BS, et al. (2010)                            <span id='am-242' about='Thesaurus:Unit' typeof='owl:Thing'>unit</span> controls melanization affects longevity mosquitoes. Cell Mol Life <br />     Transcriptome changes Culex quinquefasciatus (Diptera: Culicidae) salivary                Sci 68: 1929&#226;&#8364;&#8220;1939. <br />     glands West Nile virus infection. J Med Entomol 47: 421&#226;&#8364;&#8220;435.                      50. Attarzadeh-Yazdi G, Fragkoudis R, Chi Y, Siu RW, Ulper L, et al. (2009) Cell- <br /> 22. Sanders HR, Foy BD, Evans AM, Ross LS, Beaty BJ, et al. (2005) Sindbis virus                 to-cell spread RNA interference response suppresses Semliki Forest virus <br />     induces transport processes alters expression innate immunity pathway                 (SFV) infection mosquito cell cultures antagonized SFV. <br />     genes midgut disease vector, Aedes aegypti. Insect Biochem Mol                 J Virol 83: 5735&#226;&#8364;&#8220;5748. <br />     Biol 35: 1293&#226;&#8364;&#8220;1307.                                                                      51. Kanost MR, Gorman MJ (2008) Phenoloxidases insect immunity. In: Beckage <br /> 23. Souza-Neto JA, Sim S, Dimopoulos G (2009) An evolutionary conserved                          NE, editor. Insect Immunology. San Diego: Academic Press. pp. 69&#226;&#8364;&#8220;96. <br />     function JAK-STAT pathway anti-dengue defense. Proc Natl Acad                  52. Castillo J, Brown MR, Strand MR (2011) Blood feeding insulin-like peptide <br />     Sci U S A 106: 17841&#226;&#8364;&#8220;17846.                                                                  3 stimulate proliferation hemocytes mosquito Aedes aegypti. PLoS <br /> 24. Xi Z, Ramirez JL, Dimopoulos G (2008) The Aedes aegypti Toll Pathway                         Pathog 7: e1002274. <br />     Controls Dengue Virus Infection. PLoS Pathogens 4: e1000098.                             53. Castillo JC, Robertson AE, Strand MR (2006) Characterization hemocytes <br /> 25. Waldock J, Olson KE, Christophides GK (2012) Anopheles gambiae Antiviral                     mosquitoes Anopheles gambiae Aedes aegypti. Insect Biochem <br />     Immune Response Systemic O&#226;&#8364;&#8482;nyong-nyong Infection. PLoS Negl Trop Dis                      Mol Biol 36: 891&#226;&#8364;&#8220;903. <br />     6: e1565.                                                                                54. Clark KD, Lu Z, Strand MR (2010) Regulation melanization glutathione <br /> 26. Fragkoudis R, Chi Y, Siu RW, Barry G, Attarzadeh-Yazdi G, et al. (2008)                      moth Pseudoplusia includens. Insect Biochem Mol Biol 40: 460&#226;&#8364;&#8220;467. <br />     Semliki Forest virus strongly reduces mosquito host defence signaling. Insect Mol        55. Cirimotich CM, Scott JC, Phillips AT, Geiss BJ, Olson KE (2009) Suppression <br />     Biol 17: 647&#226;&#8364;&#8220;656.                                                                            RNA interference increases alphavirus replication virus-associated <br /> 27. Avadhanula V, Weasner BP, Hardy GG, Kumar JP, Hardy RW (2009) A novel                        mortality Aedes aegypti mosquitoes. BMC Microbiol 9: 49. <br />     launch alphavirus RNA synthesis reveals role Imd             56. Myles KM, Wiley MR, Morazzani EM, Adelman ZN (2008) Alphavirus-derived <br />     pathway arthropod antiviral response. PLoS Pathog 5: e1000582.                            small RNAs modulate pathogenesis disease vector mosquitoes. Proc Natl Acad <br /> 28. Cerenius L, Lee BL, Soderhall K (2008) The proPO-system: pros cons               Sci U S A 105: 19938&#226;&#8364;&#8220;19943. <br />     role invertebrate immunity. Trends Immunol 29: 263&#226;&#8364;&#8220;271.                               57. Davies AM, Yoshpe-Purer Y (1954) The transmission Semliki Forest virus by <br /> 29. Christensen BM, Li J, Chen CC, Nappi AJ (2005) Melanization immune                           Aedes aegypti. J Trop Med Hyg 57: 273&#226;&#8364;&#8220;275. <br />     responses mosquito vectors. Trends Parasitol 21: 192&#226;&#8364;&#8220;199.                             58. Woodall JP, Bertram DS (195 <br /> </body></html>